Pregabalin, marketed as Lyrica, is facing scrutiny from public health experts due to its rising rates of abuse and the alarming number of associated deaths. Initially prescribed for nerve pain, epilepsy, and anxiety, its euphoric effects have led to increased misuse, especially when combined with opioids like heroin and methadone. Experts are urging for its reclassification as a controlled substance in response to these growing concerns, mirroring past concerns about other medications. The call for action arises from the desire to prevent further addiction and fatalities related to the misapplication of this medication.
Public health experts stress that pregabalinâs abuse, particularly in conjunction with opioids, is a growing concern leading to increased fatalities, warranting its reclassification.
As more cases of misuse emerge, health professionals advocate for pregabalin to be classified as a controlled substance to mitigate addiction risks.
Collection
[
|
...
]